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Abstract—On the basis of the HIV infection dynamics model
proposed by ADAMS in [1], we propose an extended model
that aims at incorporating the influence of activation-induced
apoptosis of CD4+ and CD8+ T-cells on the immune system
response of HIV infected patients. Through this model we study
the influence of this phenomenon on the time evolution of
specific cell populations such as plasma concentrations of HIV
copies, or blood concentrations of CD4+ and CD8+ T-cells. In
particular, this study shows that depending on its intensity, the
apoptosis phenomenon can either favour or mitigate the long-
term evolution of the HIV infection.
Index Terms—HIV infection dynamics, activation-induced
apoptosis, nonlinear model analysis.
I. INTRODUCTION
The human Immunodeficiency Virus (HIV) is a retrovirus
that may lead to the lethal Acquired Immune Deficiency Syn-
drome (AIDS). After initial contact and inclusion of the HIV
particle into specific types of cell of the immune system, there
is a cascade of intracellular events leading to the production
of massive numbers of new viral copies, the death of infected
cells, and ultimately the devastation of the immune system.
Since the first identification of the disease in 1981, intensive
studies have been carried out to understand the fundamental
HIV infection mechanisms. HIV primarily infects cells of the
human immune system such as helper T-cells (specifically
CD4+ T-cells), macrophages and dendritic cells. When the
number of CD4+ T-cells declines below a critical level, cell-
mediated immunity1 is lost, and the body becomes progres-
sively more susceptible to opportunistic infections. Progression
from HIV infection to AIDS is primarily due to an extensive
depletion of CD4+ T-cells.
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1Cell-mediated immunity is an immune response that does not involve
antibodies but rather involves the activation of macrophages, natural killer
cells, antigen-specific cytotoxic T-lymphocytes, and the release of various
cytokines in response to an antigen.
Several mechanisms are involved in the loss of CD4+ T-
cells and this topic is one of the most controversial issues
in recent AIDS research. T-cell loss may be due to direct
destruction by the virus (direct virus-induced cytolysis) or
to defective T-cell generation. In 1991, apoptosis, also called
programmed cell death, has been suggested as another mech-
anism responsible for T-cell depletion during the evolution
of HIV-1 infection and an extensive body of recent literature
is supporting this hypothesis ([2], [3], [4], [5], [6]). In HIV-
infected patients, both infected and uninfected cells undergo
accelerated apoptosis but, remarkably, the vast majority of the
cells that undergo apoptosis are uninfected ([7]). Furthermore,
the level of apoptosis in HIV-1 infected patients is correlated
to the levels of circulating CD4+ T-cells and the stage of
disease ([7]), which reinforces the idea that apoptosis induced
by the HIV infection plays an important role in the death of
the lymphocytes.
Mathematical analysis of the HIV/AIDS infection is actively
studied since the middle of the 90’s. Several authors have
proposed mathematical models to describe the HIV infection
dynamics (e.g. [1], [8], [9], [10], [11], [12]). These models are
often represented by a set of nonlinear Ordinary Differential
Equations (ODEs) which model the long-term interaction
between the immune system and the virus. They generally take
into consideration several biological phenomena that influence
the infection process, but, to the best of our knowledge, no
mathematical model has yet tried to explain the influence
of the activation-induced apoptosis phenomenon on the HIV
infection dynamics.
In this paper, we propose a modification of the model
proposed by ADAMS et al. in [1]. This modification aims
at modelling the activation-induced apoptosis phenomenon
and analyse its influence on the HIV infection dynamics.
Similarly to the model initially proposed by Adams et al.,
our model is characterised by different equilibrium points and
does not directly aim at predicting the long-term collapse of
the immune system, which may be due to several factors such
as virus mutations or fatigue of the immune system resulting
in progressive thymus degradation.
The paper is organised as follows. Section II introduces our
proposed mathematical model for the influence of apoptosis
on the HIV infection dynamics. In Section III we analyse the
properties of this model by relying both on simulations and
nonlinear bifurcation analysis. Finally, we discuss the impli-
cations and limitations of the proposed model in Section IV.
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II. APOPTOSIS-COMPLIANT MODEL FOR THE HIV
INFECTION DYNAMICS
Section II-A briefly describes the model of ADAMS et al.
introduced in [1]. Based on this model, we propose in Section
II-B an extension which takes into account the activation-
induced apoptosis phenomenon.
A. The model of ADAMS et al.
The model of ADAMS et al. introduced in [1] is a com-
partmental ordinary differential equation model in which each
compartment corresponds to a specific type of cell population.
The model predicts the time evolution of specific cell popu-
lations such as for example blood concentrations of CD4+ T-
lymphocytes and plasma concentration of HIV virions. More
specifically, it is described by the following set of ordinary
differential equations2
T˙1 = λ1 − d1T1 − k1V T1 (1)
T˙2 = λ2 − d2T2 − k2V T2 (2)
T˙ ∗1 = k1V T1 − δT
∗
1 −m1ET
∗
1 (3)
T˙ ∗2 = k2V T2 − δT
∗
2 −m2ET
∗
2 (4)
V˙ = NT δ (T
∗
1 + T
∗
2 )− cV (5)
− (ρ1k1T1 + ρ2k2T2)V
E˙ = λE +
bE (T
∗
1 + T
∗
2 )
(T ∗1 + T
∗
2 ) + Kb
E (6)
−
dE (T
∗
1 + T
∗
2 )
(T ∗1 + T
∗
2 ) + Kd
E − δEE
where T1 (T ∗1 ) denotes the number of non-infected (infected)
CD4+ T-lymphocytes (in cells/ml), T2 (T ∗2 ) the number
of non-infected (infected) macrophages (in cells/ml), V the
number of free HIVs (in virions/ml) and E the number of
HIV-specific cytotoxic CD8+ T-cells (in cells/ml).
The values of the different parameters of the model are
taken from [1]: λ1 = 10, 000 ( cellsml×day ), d1 = 0.01 ( 1day ),
k1 = 8×10
−7 ( ml
virions×day
), λ2 = 31.98 ( cellsml×day ), d2 = 0.01
( 1
day
), f = 0.34, k2 = 10−4 ( mlvirions×day ), δ = 0.7 ( 1day ),
m1 = 10
−5 ( ml
cells×day
), m2 = 10−5 ( mlcells×day ), NT = 100
( virions
cells
), c = 13 ( 1
day
), ρ1 = 1 ( virionscells ), ρ2 = 1 ( virionscells ),
λE = 1 ( cellsml×day ), bE = 0.3 ( 1day ), Kb = 100 ( cellsml ), dE =
0.25 ( 1
day
), Kd = 500 ( cellsml ), δE = 0.1 ( 1day ).
As a general remark, some side simulations have shown that
all the results presented in this paper are qualitatively robust
with respect to perturbations of the nominal parameter values
listed above. We therefore, only consider these nominal values
in the presented results.
In order to provide insight into the properties of this model,
we briefly discuss its main characteristics.
2The model proposed in [1] also includes two control inputs representing
the effect of the two main types of drugs (Protease Inhibitors and Reverse
Transcriptase Inhibitors) typically used in Highly Active Anti-Retroviral
Therapy (HAART). In this paper, we specifically focus on the mathematical
modelisation of activation-induced apoptosis for non-treated patients and
therefore do not consider these two control inputs.
As shown in [1], the system of ordinary differential equa-
tions (1)-(6) exhibits four physical equilibrium points (and
several non physical ones, omitted here, for which one or
several state variables are negative). The first three physical
equilibrium points have a clear biological interpretation. The
fourth equilibrium point has no clear biological interpretation
and can be shown to be locally unstable. Nevertheless this lat-
ter equilibrium point plays an important role in the apoptosis-
compliant dynamics as we will discuss later in Section III.
These physical equilibrium points are respectively
1) an uninfected unstable equilibrium point
(T1, T2, T
∗
1 , T
∗
2 , V, E)eq
=
(
106, 3198, 0, 0, 0, 10
)
2) an infected, so-called “healthy”, locally stable equilib-
rium point
(T1, T2, T
∗
1 , T
∗
2 , V, E)eq
= (967839, 621, 76, 6, 415, 353104)
which corresponds to a small viral load, a high CD4+
T-lymphocytes count and a high HIV-specific cytotoxic
T-cells count,
3) an infected, so-called “non-healthy”, locally stable equi-
librium point
(T1, T2, T
∗
1 , T
∗
2 , V, E)eq
= (163573, 5, 11945, 46, 63919, 24)
for which T-cells are depleted and the viral load is very
high.
4) an infected locally unstable equilibrium point
(T1, T2, T
∗
1 , T
∗
2 , V, E)eq
= (664938, 50, 1207, 11, 6299, 207658)
Numerical simulations show that the basin of attraction of
the “healthy” steady-state is relatively small in comparison
with the one of the “non-healthy” steady-state. Furthermore,
perturbation of the uninfected steady-state by adding as less
as one single HIV per ml of blood plasma leads to asymptotic
convergence towards the “non-healthy” steady-state as can be
seen in Figure 1.
B. Incorporation of the apoptosis phenomenon into the model
of ADAMS et al.
Apoptosis, also called programmed cell death, is is a process
of deliberate life relinquishment by a cell in a multicellular
organism. It is an important biological process whose main
goal is to eliminate selected cells for the benefit of the
whole organism. Apoptosis can, for example, occur when
a cell is damaged beyond repair, infected with a virus, or
undergoing stress conditions such as starvation. The “decision”
for apoptosis can either come from the cell itself, or be induced
from its surrounding environment (see [13] for a general
introduction on apoptosis).
In the special case of lymphocytes, apoptosis plays an
important role in optimising the functions of the immune
system by compensating lymphocytes proliferation through
the elimination of cells that have become ill or ineffective.
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Fig. 1. Time evolution of the state variables of the model (1)-(6) start-
ing from the primo-infection initial condition
`
T1, T2, T
∗
1 , T
∗
2 , V,E
´
=`
106, 3198, 0, 0, 1, 10
´
.
When apoptosis is not influenced by the presence of other
cells, its effect can be considered as constant during the HIV
infection, i.e. the death rates of the cells related to apoptosis
does not change with the evolution of the disease. In such a
context, apoptosis is generally included in the natural death
rate of each cell (represented by the terms −d1T1, −d2T2,
−δEE and, to a certain extent, −δT ∗1 and −δT ∗2 in the model
(1)-(6)). However, this is cannot be the case for environment
dependent apoptosis. Indeed, as reported in [2] and [5], lymph
nodes of HIV-infected individuals contain a high percentage
(with respect to uninfected individuals) of uninfected CD4+
and CD8+ cells which are in an apoptotic state – that is which
are ready to enter into an apoptotic process. Furthermore, these
studies also showed that the apoptosis rates of these apoptotic
cells were dependent on the stage of evolution of the HIV
infection, and more specifically on the number of infected
cells. As a general conclusion of these observations, the per-
day proportion of uninfected but apoptotic CD4+ and CD8+
T-cells must be dependent on the number of infected cells and
thus cannot be represented by constant factors (d1, d2, δE , or
δ) as is the case for spontaneous apoptosis.
From a biological point of view, uninfected CD4+ and
CD8+ T-cells have been shown to be prematurely marked
for apoptosis due to the presence of biochemical messengers,
for example the glycoprotein gp120, one of the most well
established apoptosis-inducing factor ([3], [4]). As summarised
in [14] and [15], there are several main potential sources for
apoptosis-inducing factors: infected cells or free virus particles
expressing gp120 on their surface, soluble gp120 alone, and
Tat viral proteins. Other viral proteins, such as the accessory
protein Nef [16] and possibly the immediate-early protein Vpr
[17] may also induce apoptosis. Furthermore, some references
(e.g. [3]) suggest the existence of a two step mechanism in
which, firstly, T-cells are primed for a premature death by
interaction with gp120, and secondly, the actual death signal
is delivered by membrane-bound TNF-alpha on the surface of
macrophages.
For the sake of obtaining a model which is able to quali-
tatively capture the activation-induced apoptosis phenomenon
without becoming too complex for its analysis, we assume
that all the potential apoptosis-inducing factors are directly
correlated with the concentration of HIV-infected CD4+ T-
cells (T ∗1 ) and that the activation-induced apoptosis signalling
does not involve macrophages. Finally, we assume that the per-
day apoptosis proportions depend linearly on the concentration
of infected CD4+ T-cells3.
Consequently, we propose the following modification of the
non-infected CD4+ T-cells dynamics: T˙1 = λ1 − d1T1 −
k1V T1 − δT1T1 where δT1 (expressed in 1day ) denotes the
activation-induced apoptosis proportion of non-infected CD4+
T-cells. According to our previously described assumptions,
we assume that δT1 depends solely on T ∗1 , i.e. T˙1 = λ1 −
d1T1−k1V T1−δT1 (T
∗
1 )T1. Finally, assuming this dependence
on T ∗1 to be linear, we obtain that δT1 (T ∗1 ) = aT1T ∗1 where aT1
is a non negative parameter (expressed in ml
cells×day
) called the
activation-induced apoptosis parameter of uninfected CD4+ T-
cells when in presence of infected CD4+ T-cells (or apoptosis
parameter for short). A similar modification is considered for
the dynamics of CD8+ cells. The corresponding modified
model writes:
T˙1 = λ1 − d1T1 − k1V T1 − aT1T
∗
1 T1 (7)
T˙2 = λ2 − d2T2 − k2V T2 (8)
T˙ ∗1 = k1V T1 − δT
∗
1 −m1ET
∗
1 (9)
T˙ ∗2 = k2V T2 − δT
∗
2 −m2ET
∗
2 (10)
V˙ = NT δ (T
∗
1 + T
∗
2 )− cV (11)
− (ρ1k1T1 + ρ2k2T2)V
E˙ = λE +
bE (T
∗
1 + T
∗
2 )
(T ∗1 + T
∗
2 ) + Kb
E (12)
−
dE (T
∗
1 + T
∗
2 )
(T ∗1 + T
∗
2 ) + Kd
E − δEE − aET
∗
1E
where aT1 and aE are expressed in mlcells×day .
III. ANALYSIS OF THE APOPTOSIS-COMPLIANT MODEL
In this section, we analyse the HIV infection dynamics
model described by the system of ODEs (7)-(12). This analysis
mainly focuses on the study of the influence of the apoptosis
parameters aT1 and aE on the modelled dynamics.
In order to study the influence of some parameters on
the dynamics of a nonlinear system modelled by ODEs,
one generally relies on a combination of two complementary
3It would also, for example, make sense to consider that the infected
CD4+ T-cells, macrophages, and free HIV are correlated with the apoptosis-
inducing factors. However, some side simulations and analysis not reported
in this paper, have shown that replacing the term aT1T ∗1 by the term
aT1
`
αT ∗1 + βT
∗
2 + (1− α− β)V
´
with α, β ∈ [0, 1] and α + β = 1
yields results which are qualitatively quite similar. This can be explained by
the fact that the time evolutions of infected CD4+ T-cells, macrophages, and
virions predicted by our model are highly correlated. The main reason for
having adopted the simpler term aT1T ∗1 was to obtain a model which could
capture the fundamental dynamics associated with the activation-induced
apoptosis phenomenon, while, at the same time, being simple enough to lend
itself to a detailed analysis.
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approaches. The first one is a simulation based approach
which consists in numerically integrating the set of ODEs for
different values of the system parameters (and often also for
different initial conditions). The second one is more analytical
and relies on a bifurcation analysis of the system with respect
to the parameters of interest. This second approach aims at
establishing the influence of the parameters of interest on the
number, the stability and the position of the attractors of the
system.
More specifically, the simulation part allows us to iden-
tify typical asymptotic behaviours exhibited by the proposed
model and to determine the time needed to reach a specific
neighbourhood of these asymptotic behaviours. On the other
hand the bifurcation analysis provides a better insight into the
dynamic mechanisms that correlate the apoptosis parameters
aT1 and aE with these asymptotic behaviours.
For the sake of simplicity, the analysis will start by con-
sidering that aE is equal to zero which is equivalent to
neglecting activation-induced apoptosis in the dynamics of
CD8+ T-cells. Afterwards, we study the case where both aT1
and aE are different from zero. To lighten the presentation
of the results, we will mainly consider in our study a sin-
gle initial state corresponding to the primo-infection point
(T1, T2, T
∗
1 , T
∗
2 , V, E) = (10
6, 3198, 0, 0, 1, 10) and limit the
range of values for aT1 and aE to [0, 1]. While this may
seem to be restrictive, we found that the qualitative nature
of our results were very robust with respect to “biologically
plausible” initial conditions. Furthermore, we believe that for
values of aT1 and aE greater than 1, the modelled activation-
induced apoptosis rates become so important that they cannot
remain in adequacy with reality. Indeed, such high values
of the apoptosis parameters would yield an almost complete
depletion of the T-cells within less than a few minutes.
A. Simulation results for aT1 ∈ [0, 1] and aE = 0
By numerically integrating the model (7)-(12) starting from
various initial conditions for different values of aT1 ∈ [0, 1],
we have always observed convergence to an equilibrium point.
However, the position of this equilibrium was found to be
highly dependent on the value of the apoptosis parameter aT1 .
For 0 ≤ aT1 ≤ 3.874 × 10−5, this position evolves continu-
ously when the values of aT1 are increased, and remains very
close to the position of the “non-healthy” equilibrium point
corresponding to aT1 = 0. At the particular threshold value
aT1 = 3.874× 10
−5
, there is a sudden “jump” towards a new
position for which the corresponding asymptotic values of the
state variables can be associated to a “healthier” situation, i.e.
the viral load and infected cells concentrations are drastically
decreased while the non-infected and HIV-specific cytotoxic
T-cells concentrations are significantly increased. However,
beyond the threshold value aT1 = 3.874×10−5, this previously
described healthier situation steadily degrades with increasing
values of aT1 . For values of aT1 greater than say 10−3,
convergence to a point which is “less healthy” than the “non-
healthy” equilibrium point described in Section II-A occurs.
In Figure 2, we represent three typical time evolutions for
the state variables of the model (7)-(12) when starting from the
primo-infection point. These three time evolutions correspond
to the following apoptosis parameter values aT1 = 10−5,
aT1 = 10
−4
, and aT1 = 10−2, respectively.
Up to this point, we have mainly focused on the study of
the properties of the system (7)-(12) in asymptotic conditions.
However, as illustrated in Figure 3, the time needed to reach
a close neighbourhood of the asymptotic equilibrium values
may be large4. In particular, the time needed for the state-
space trajectories to reach a neighbourhood of the equilibrium
point to which they asymptotically converge is significantly
increasing around the threshold value aT1 = 3.874 × 10−5.
This latter observation together with the fact that during
the transient period the state variables deviation with respect
to their asymptotic value may be significant (see Figure 2)
show that the transient dynamics and settling-time must also
be taken into consideration when studying the effects of
activation-induced apoptosis.
In order to get a better insight into the influence of the
apoptosis parameter aT1 on the dynamics of the proposed
model, and especially to understand why there exists a range
of values for aT1 for which the patient state converges to an
equilibrium point which is significantly “healthier” than the
“non-healthy” equilibrium point described in Section II, we
perform, in Section III-B, a detailed bifurcation analysis.
B. Bifurcation analysis for aT1 ∈ [0, 1] and aE = 0
We performed a bifurcation analysis of the equilibrium
points of the model (7)-(12) by relying on the numerical tool
MATCONT5 [18]. The results of this bifurcation analysis are
given in Figure 4 where the physical infected equilibrium point
values of T1 are represented as a function of the apoptosis
parameter aT1 . The unstable uninfected equilibrium point
value of T1 is independent of aT1 and is thus not represented.
This bifurcation diagram helps in understanding the dif-
ferent observed behaviours. For values of aT1 in the range
[0, 3.874 × 10−5[, three equilibrium points coexist, two of
them are locally stable (eq. point 1 and eq. point 2) while
the remaining one is unstable. The asymptotic behaviour of
the system depends on the chosen initial condition for the
model. Performing simulations for a large number of “biolog-
ically plausible” initial conditions, we have always observed
convergence to one of the two locally stable equilibrium
points. Furthermore, considering aT1 ∈ [0, 3.874 × 10−5[
and starting from the primo-infection initial condition or a
perturbed version of this initial condition6, convergence to the
“non-healthy” stable equilibrium point (eq. point 2) has always
4Some side simulations have shown that a significant increase in the
settling-time values around the bifurcation threshold always occurs indepen-
dently of the chosen initial condition. Therefore, the results presented in Figure
3 for the primo-infection initial condition can be considered as representative
for any initial condition.
5MATCONT is a MATLAB toolbox incorporating various numerical differ-
ential equation solvers and continuation algorithms for bifurcation analysis.
It is freely available at http://www.matcont.ugent.be/.
6During the simulations, we have considered perturba-
tions for which the initial concentrations are defined as“
k1T1pi , k2T2pi , k3T
∗
1pi
, k4T
∗
2pi
, k5Vpi, k6Epi
”
with ki,
i = 1, · · · , 6 randomly chosen in the interval [0.75, 1.25] and“
T1pi , T2pi , T
∗
1pi
, T ∗2pi
, Vpi, Epi
”
= (106, 3198, 0, 0, 1, 10).
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Fig. 2. Time-evolution of the state variables of the model (7)-(12) for
different values of the apoptosis parameter aT1 : aT1 = 10−5 (top),
aT1 = 10
−4 (middle), and aT1 = 10−2 (bottom). For every graph, the
model has been numerically integrated starting from the primo-infection initial
condition
`
T1, T2, T
∗
1 , T
∗
2 , V,E
´
=
`
106, 3198, 0, 0, 1, 10
´
and the effect
of activation-induced apoptosis on the dynamics of the CD8+ T-cells has been
neglected (i.e., aE = 0).
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Fig. 4. Bifurcation diagram of the equilibrium concentrations of non-infected
CD4+ T-cells (T1eq ) when the bifurcation parameter aT1 varies from 0 to
10−4. A saddle-node bifurcation point (LP1) exists at aT1 = 3.874×10−5 .
Only the infected equilibrium points (equilibrium points 2, 3 and 4) are
represented and aE is chosen equal to 0. The equilibrium points at aT1 = 0
correspond to the three infected equilibrium points of the model (1)-(6)
described in Section II-A.
been observed. This latter observation confirms that the basin
of attraction of the “healthy” equilibrium point (eq. point 1) is
much smaller when compared to the one of the “non-healthy”
equilibrium point (eq. point 2). At aT1 = 3.874 × 10−5, the
“non-healthy” equilibrium point (eq. point 2) coalesces with
the unstable one through a saddle-node (also called limit point)
bifurcation. We denote this point by LP1 where LP stands for
limit point. For values of aT1 in the range [3.874× 10−5, 1],
a single locally stable equilibrium point exists (eq. point 1).
Furthermore, as aT1 increases towards 1, the position of this
locally stable equilibrium (eq. point 1) evolves in such a
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way that T1eq , T2eq and Eeq decrease while T ∗1eq , T
∗
2eq
and
Veq increase, explaining the previously simulation-observed
degradation in the patient state.
Remark: If one performs a bifurcation analysis for negative
values of aT1 , a second saddle-node bifurcation point appears,
where eq. point 1 coalesces with the unstable equilibrium
point. We denote this point by LP2. This point LP2 has not
been represented in Figure 4 since negative values of aT1
make no biological sense in our model. Nevertheless noticing
the existence of this second saddle-node bifurcation point is
important in order to understand the two-parameter bifurcation
analysis presented in Section III-C.
C. Analysis for aT1 ∈ [0, 1] and aE ∈ [0, 1]
In this section, we additionally include the effect of
activation-induced apoptosis on the CD8+ T-lymphocytes and
thus consider the model (7)-(12) where both aT1 and aE
may take non-zero values. We first describe the results of
a bifurcation analysis encompassing both the parameters aT1
and aE . Afterwards, we discuss the additional information that
simulations can bring with respect to this analysis. This two-
parameter bifurcation analysis is based on a numerical con-
tinuation of the saddle-node bifurcation point LP1 occurring
at (aT1 , aE) =
(
3.874× 10−5, 0
) (see [19], [20] for details
about the continuation algorithm used). The corresponding
two-parameter continuation diagram is given in Figure 5. On
this latter figure, we can see that a CUSP bifurcation point7
exists at (aT1 , aE) =
(
4.838× 10−4, 1.956× 10−4
)
. At this
point two branches, LP1 and LP2, of saddle-node bifurcation
curves meet tangentially. These two branches divide the pa-
rameter plane into two regions. Inside the wedge between LP1
and LP2, there are three equilibria, two stable (eq. points 1
and 2) and one unstable. Outside the wedge, there is a single
equilibrium, which is stable. This equilibrium point may be
either eq. point 1 or eq. point 2 depending if we are below
LP1 or above LP2. If we approach the CUSP point from inside
the LP1-LP2 wedge, all three equilibria merge together so
that only a single stable equilibrium point remains beyond the
CUSP bifurcation point.
To obtain a clear understanding of the influence of the two
activation-induced apoptosis parameters aT1 and aE on the set
of reached equilibrium points when starting from the primo-
infection initial condition we consider the 3D plot given in
Figure 6.
Figure 6 represents for different values of (aT1 , aE) the
value of T1 corresponding to the equilibrium point to which
the patient’s state converges when starting from the primo-
infection initial condition. Similarly to what we observed
in Section III-B, we see that there exist ranges of values
of aT1 and aE where activation-induced apoptosis can have
a beneficial effect that hinders the progression of the HIV
infection. These values are located below the LP1 curve in the
(aT1 , aE)-plane (see Figure 5). For any fixed value of aE in
7At the CUSP bifurcation point two branches of saddle-node bifurcation
curves meet tangentially. For nearby parameter values, the system can have
three equilibria which collide and disappear pairwise via the saddle-node
bifurcations.
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the range [0, 1.956×10−4], by increasing the value of aT1 just
above the corresponding threshold value defined by the LP1
curve, there is a sudden change in the value of T1 associated
with the convergence point. This is due to the fact that below
the LP1 curve given in Figure 5, the system converges to
an equilibrium point parented with the “healthy” equilibrium
point (eq. point 1), as defined in Section III-A, while above this
curve it converges to a point parented with the “non-healthy”
equilibrium (eq. point 2). Increasing the value of aT1 further
beyond this LP1-defined threshold value, the “healthiness”
(measured in proportion with the corresponding value of T1eq )
of the convergence point decreases with increasing values of
aT1 . It is also important to notice that for any value of aT1 ,
the “healthiness” of the convergence point always decreases
with aE . These two parameters do not have the same effect
on the HIV infection as can be seen from the asymmetry
of the graphs given in Figures 5 and 6. Actually, this can
be explained by the fact that the death of CD4+ T-cells by
activation-induced apoptosis can mitigate the HIV infection
by limiting the number of cells in which the HIV can copy
itself while this is not the case for CD8+ T-cells since they are
not directly targeted by HIVs in our model. Also, and similar
to what we showed in Section III-A, we found that the settling
time, i.e. the time needed to reach a small neighbourhood
of the asymptotically reached equilibrium point, becomes
particularly large for (aT1 , aE) values located close to the LP1
curve.
IV. DISCUSSION
Based on the HIV infection dynamics model proposed by
ADAMS in [1], we have proposed an extended model which
aims at incorporating the apoptosis-inducing effects that the
HIV infection has on non-infected CD4+ and CD8+ T-cells.
The part of this model specific to these activation-induced
apoptosis phenomena depends upon two apoptosis parameters
which determine its magnitude (aT1 and aE). Using a combi-
nation of numerical simulations and bifurcation analysis, we
found that for some ranges of values of these parameters, these
activation-induced apoptosis phenomena could have some ben-
eficial effects on the control of the HIV infection. Indeed, in
those ranges, the effect of activation-induced apoptosis modi-
fies the time evolution of the CD4+ T-cells concentrations in a
way which is particularly beneficial for preserving the immune
system integrity. On the other hand, when the magnitude of
the apoptosis parameters becomes too large, this potential
beneficial effect disappears and activation-induced apoptosis
mechanisms were then found to aggravate the HIV infection.
Furthermore, since the HIV infection worsens when these
activation-induced apoptosis rates become too large, one could
also relate the progression of the HIV infection to AIDS to a
change of magnitude in these rates. These findings need to be
taken with caution since they are dependent on several mod-
elling assumptions (per-day apoptosis proportions are linearly
proportional to the concentration of infected CD4+ cells and
the propensity non-infected CD4+ and CD8+ cells have to
undergo apoptosis is proportional to their concentration) that
would certainly require careful experimental validation.
We emphasise that these results could also potentially help
in designing new anti-HIV therapies based on a drug-mediated
regulation of the activation-induced apoptosis factors (such as
gp120) in HIV infected patients. These therapies could be
based on the injection of some specific interleukins8 to HIV
positive patients, such as for example IL-2, IL-7 and IL-15.
Indeed, the anti-apoptotic effect of these interleukins has been
reported in the literature [14], [21], [7]. For example, reference
[14] suggests that IL-15 could be used as an immunorestorative
agent in HIV treatment because of its anti-apoptotic properties,
and its role in enhancing survival and functions of CD8+ T-
cells. Also, the in-vitro results presented in [7] highlight the
beneficial anti-apoptotic effects of IL-2 and IL-7 on CD4+
and CD8+ T-cells of HIV infected patients. However, the
role of interleukins on the immune system of HIV-infected
patients/macaques is still a controversial issue since other
studies (see e.g. [22]) have shown that they could have a
detrimental effect. Nevertheless, these contradictory results
concerning the effects of interleukins on the HIV infection
could potentially be explained by the analysis of our extended
model, which shows that a decrease in apoptosis rates does
not necessarily lead to a better immune system response.9
Finally, we acknowledge that the model proposed in this
paper possesses some limitations. In particular, similarly to the
model initially proposed by ADAMS et al., our model is not
able to predict the in-vivo observed long-term collapse of the
immune system, which may be due to several factors such as
virus mutations, or fatigue of the immune system resulting in
progressive thymus degradation. In ongoing research we inves-
tigate some modifications of the proposed model to overcome
these limitations. Also, our model does not encompass the
effects of Highly Active Anti-Retroviral (HAART) drugs and
of activation-induced apoptosis on the HIV dynamics. More
research would certainly be useful to explore ways to design
models that overcome these two limitations.
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